News
-
-
-
-
-
-
PRESS RELEASE
New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine
NRx Pharmaceuticals granted Suitability Petition by FDA for preservative-free ketamine product, enabling re-filing of ANDA for KETAFREE™ and addressing critical policy objectives -
PRESS RELEASE
New to The Street's Esteemed Client Aeries Technology Announces Major Enterprise Client Expansion, Projected to Reach $12M+ Annualized Run-Rate by Fiscal Year-End
Aeries Technology expands engagement with a global enterprise client, driving annual revenue run-rate above $12 million by fiscal year-end. New to The Street highlights the growth trajectory of Aeries Technology and its success in securing major enterprise expansions -
PRESS RELEASE
Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition
Jaguar Health's Napo Pharmaceuticals submits orphan drug designation application to FDA for crofelemer in treating diarrhea in adult patients with breast cancer metastasized to the brain, targeting expedited regulatory pathways -
PRESS RELEASE
Prince Silver Announces Non-Brokered Private Placement and Strategic Marketing Partnership with Machai Capital
Prince Silver Corp. announces non-brokered private placement for exploration program in Nevada, USA. Marketing agreement signed with Machai Capital Inc. for digital marketing services -
